Moebus, K; Siepmann, J; Bodmeier, R. Novel preparation techniques for alginate-poloxamer microparticles controlling protein release on mucosal surfaces. European Journal of Pharmaceutical Sciences 45, 358-366, 2012. doi:10.1016/j.ejps.2011.12.004

Delplace, C; Kreye, F; Klose, D; Danede, F; Descamps, M; Siepmann, J; Siepmann, F. Impact of the experimental conditions on drug release from parenteral depot systems: From negligible to significant. International Journal of Pharmaceutics 432, 11-22, 2012. doi:10.1016/j.ijpharm.2012.04.053

Moebus, K; Siepmann, J; Bodmeier, R. Zinc-Alginate-Microparticles for Controlled Pulmonary Delivery of Proteins Prepared by Spray-Drying. European Journal of Pharmaceutics and Biopharmaceutics 81, 121-130, 2012. doi:10.1016/j.ijpharm.2012.04.053

Kreye, F; Hamm, G; Karrout, Y; Legouffe, R; Bonnel, D; Siepmann, F; Siepmann, J. MALDI-TOF MS Imaging of controlled release implants. Journal of Controlled Release 161, 98-108, 2012. doi:10.1016/j.jconrel.2012.04.017

Gaignaux, A; Reeff, J; Siepmann, F; Siepmann, J; De Vriese, C; Goole, J; Amighi, K. Development and evaluation of sustained-release clonidine-loaded PLGA microparticles International Journal of Pharmaceutics 437, 20-28, 2012. doi:10.1016/j.ijpharm.2012.08.006

Blanchemain, N; Karrout, Y; Tabary, N; Bria, M; Neut, C; Hildebrand, HF; Siepmann, J; Martel, B. Comparative study of vascular prostheses coated with different polycyclodextrins for controlled ciprofloxacin release. Carbohydrate Polymers 90, 1695-1703, 2012. doi:10.1016/j.carbpol.2012.07.052

Lerbret, A; Affouard, F; Hédoux, A; Krenzlin, S; Siepmann, J; Bellissent-Funel, MC; Descamps, M. How strongly does trehalose interact with lysozyme in the solid state? Insights from molecular dynamics simulation and inelastic neutron scattering. The Journal of Physical Chemistry B 116, 11103-16, 2012. doi:10.1021/jp3058096

Almeida A, Brabant L, Siepmann F, De Beer T, Bouquet W, Van Hoorebeke L, Siepmann J, Remon JP, Vervaet C. Sustained release from hot-melt extruded matrices based on ethylene vinyl acetate and polyethylene oxide. Eur J Pharm Biopharm. 82, 526-533, 2012 doi:10.1016/j.ejpb.2012.08.008

Denglehem, C; Maes, JM; Raoul, G; Ferri, J. Botulinum toxin a: Analgesic treatment for temporomandibular joint disorders. Revue De Stomatologie Et De Chirurgie Maxillo-Faciale 113, 27-31, 2012.

Elkalioubie, A; Haulon, S; Van Belle, E; Susen, S; Jude, B; Dupont, A. Abdominal aortic aneurysms in patients with coronary artery disease. Sang Thrombose Vaisseaux 24, 12-18, 2012.

Haulon, S; Perini, P. Response to letter to the editor "re: Single centre prospective comparison between contrast enhanced ultrasound and computed tomography angiography after EVAR". European Journal of Vascular and Endovascular Surgery 43, 240-241, 2012.

Lazard, DS; Vincent, C; Venail, F; Van de Heyning, P; Truy, E; Sterkers, O; Skarzynski, PH; Skarzynski, H; Schauwers, K; O'Leary, S; Mawman, D; Maat, B; Kleine-Punte, A; Huber, AM; Green, K; Govaerts, PJ; Fraysse, B; Dowell, R; Dillier, N; Burke, E; Beynon, A; Bergeron, F; Baskent, D; Artieres, F; Blamey, PJ. Pre-, per- and postoperative factors affecting performance of postlinguistically deaf adults using cochlear implants: A new conceptual model over time. Plos One 7, 2012.

Legout, L; D'Elia, P; Devos, P; Ettahar, N; Sarraz-Bournet, B; Haulon, S; Senneville, E; Leroy, O. Risk factors for methicillin-resistant staphylococcal vascular graft infection in an 11-year cohort study. Journal of Infection 64, 441-444, 2012.

Myon, L; Ferri, J; Genty, M; Raoul, G. Consequences of bony free flap's pedicle calcification after jaw reconstruction. Journal of Craniofacial Surgery 23, 872-877, 2012.

Sciote, JJ; Horton, MJ; Rowlerson, AM; Ferri, J; Close, JM; Raoul, G. Human masseter muscle fiber type properties, skeletal malocclusions, and muscle growth factor expression. Journal of Oral and Maxillofacial Surgery 70, 440-448, 2012.

Thi, THH; Morel, S; Ayouni, F; Flament, MP. Development and evaluation of taste-masked drug for paediatric medicines - application to acetaminophen. International Journal of Pharmaceutics 434, 235-242, 2012.

Vincent, C; Bebear, JP; Radafy, E; Vaneecloo, FM; Ruzza, I; Lautissier, S; Bordure, P. Bilateral cochlear implantation in children: Localization and hearing in noise benefits. International Journal of Pediatric Otorhinolaryngology 76, 858-864, 2012.

Vincent, C; Bonne, NX; Guerin, C; Lebreton, JP; Devambez, M; Dubrulle, F; Haddad, E; Schapira, S; Lejeune, JP; Vaneecloo, FM. Middle fossa approach for resection of vestibular schwannoma: Impact of cochlear fossa extension and auditory monitoring on hearing preservation. Otology & Neurotology 33, 849-852, 2012.

Siepmann J, Peppas NA. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliv Rev. 2012 doi:10.1016/j.addr.2012.09.028

J.H. Ran, G. Bénistant, C. Campagne, A. Périchaud, F. Chai, N. Blanchemain, A. Perwuelz - Characterization of nonwoven PET devices functionalized with Cationic polymer. Journal of Applied Polymer Science 124:3583-90, 2012 doi:10.1002/app.34468

Perini P, Sediri I, Midulla M, Delsart P, Gautier C, Haulon S. Contrast-Enhanced Ultrasound vs. CT Angiography in Fenestrated EVAR Surveillance: A Single-Center Comparison.  J Endovasc Ther. 19, 648-55, 2012. doi:10.1583/JEVT-12-3909R.1

Haulon S, Tyrrell MR. Commentary: graft complexity alone does not predict outcome. J Endovasc Ther. 19, 536-7, 2012. doi:10.1583/11-3807C.1

Batt M, Jean-Baptiste E, O'Connor S, Feugier P, Haulon S. Contemporary management of infrarenal aortic graft infection: early and late results in 82 patients. Vascular. 20, 129-37, 2012 doi:10.1258/vasc.2011.oa0315

Midulla M, Moreno R, Baali A, Chau M, Negre-Salvayre A, Nicoud F, Pruvo JP, Haulon S, Rousseau H. Haemodynamic imaging of thoracic stent-grafts by computational fluid dynamics (CFD): presentation of a patient-specific method combining magnetic resonance imaging and numerical simulations. Eur Radiol. 22, 2094-102, 2012. doi:10.1007/s00330-012-2465-7

Midulla M, Perini P, Sundareyan R, Lazguet Y, Dehaene A, Goyault G, Martinelli T, Haulon S. Transcatheter transcaval embolization of a type II endoleak after EVAR using a transseptal needle-sheath system. Vasc Endovascular Surg. 46, 410-413, 2012 doi:10.1177/1538574412448683

Guillou M, Bianchini A, Sobocinski J, Maurel B, D'elia P, Tyrrell M, Azzaoui R, Haulon S. Endovascular treatment of thoracoabdominal aortic aneurysms. J Vasc Surg. 56, 65-73, 2012 doi:10.1016/j.jvs.2012.01.008

Sobocinski J, d'Utra G, O'Brien N, Midulla M, Maurel B, Guillou M, Azzaoui R, Roeder B, Resch TA, Haulon S. Off-the-shelf fenestrated endografts: a realistic option for more than 70% of patients with juxtarenal aneurysms. J Endovasc Ther. 19, 165-172, 2012 doi:10.1583/11-3772.1

Rheaume P, Perini P, Daligault M, Maurel B, Sobocinski J, Azzaoui R, Laghzaoui MA, Brigadeau F, Haulon S. Total endovascular repair of an aortic arch aneurysm using an externalized transseptal guidewire technique. Ann Thorac Surg. 93, 1710-1713, 2012. doi:10.1016/j.athoracsur.2011.10.030

Sobocinski J, Resch T, Midulla M, Maurel B, Guillou M, Azzaoui R, Haulon S. Fenestrated and branched technology: what's new? J Cardiovasc Surg. 53, 73-81, 2012

Resch TA, Dias NV, Sobocinski J, Sonesson B, Roeder B, Haulon S. Development of off-the-shelf stent grafts for juxtarenal abdominal aortic aneurysms. Eur J Vasc Endovasc Surg. 43, 655-60, 2012. doi:10.1016/j.ejvs.2012.01.022

Legout L, D'Elia PV, Sarraz-Bournet B, Haulon S, Meybeck A, Senneville E, Leroy O. Diagnosis and management of prosthetic vascular graft infections. Med Mal Infect. 42, 102-109, 2012. doi:10.1016/j.medmal.2012.01.003

Spear R, Maurel B, Sobocinski J, Perini P, Guillou M, Midulla M, Azzaoui R, Tefera G, Haulon S. Technical note and results in the management of anatomical variants of renal vascularisation during endovascular aneurysm repair. Eur J Vasc Endovasc Surg. 43, 398-403, 2012. doi:10.1016/j.ejvs.2012.01.003

Delsart P, Midulla M, Sobocinski J, Achere C, Haulon S, Claisse G, Mounier-Vehier C. Predictors of poor blood pressure control assessed by 24 hour monitoring in patients with type B acute aortic dissection. Vasc Health Risk Manag. 8, 23-30, 2012. doi:10.1016/j.jmv.2011.12.001

Maurel B, Sobocinski J, Perini P, Guillou M, Midulla M, Azzaoui R, Haulon S. Evaluation of radiation during EVAR performed on a mobile C-arm. Eur J Vasc Endovasc Surg. 43, 16-21, 2012. doi:10.1016/j.ejvs.2011.09.017

Legout L, Sarraz-Bournet B, D'Elia PV, Devos P, Pasquet A, Caillaux M, Wallet F, Yazdanpanah Y, Senneville E, Haulon S, Leroy O.Characteristics and prognosis in patients with prosthetic vascular graft infection: a prospective observational cohort study. Clin Microbiol Infect. 18, 352-358, 2012. doi:10.1111/j.1469-0691.2011.03618.x

Le, V.N.P.; Hoang Thi, T.H.; Robins, E.; Flament, M.P.,Dry powder inhalers: Study of the parameters influencing adhesion and dispersion of fluticasone propionate, AAPS PharmSciTech. 13, 477-484, 2012. doi:10.1208/s12249-012-9765-8 

Krenzlin, S; Vincent, C; Munzke, L; Gnansia, D; Siepmann, J; Siepmann, F., Predictability of drug release from miniaturized implants. Journal of Controlled Release. 159, 60-68, 2012. doi:10.1016/j.jconrel.2011.12.032

Le, V.N.P.; Robins, E.; Flament, M.P., Agglomerate behaviour of fluticasone propionate within dry powder inhaler formulations, European Journal of Pharmaceutics and Biopharmaceutics. 80, 596–603, 2012. doi:10.1016/j.ejpb.2011.12.004 

Siepmann, J; Siepmann, F., Modeling of diffusion controlled drug delivery. Journal of Controlled Release. 161, 351-362, 2012. doi:10.1016/j.jconrel.2011.10.006

Degoutin, S.; Jimenez, M.; Casetta, M.; Bellayer, S.; Chai, F.; Blanchemain, N.; Neut, C.; Kacem, I.;Traisnel, M.;Martel, B., Anticoagulant and antimicrobial finishing of non-woven polypropylene textiles,Biomed. Mater. 2012, 7, 035001. doi:10.1088/1748-6041/7/3/035001

Le, V.N.P.; Bierend, H.; Robins, E.; Steckel, H.; Flament, M.P., Influence of the lactose grade within dry powder formulations of fluticasone propionate and terbutaline sulphate, International Journal of Pharmaceutics 2012, 422, 75-82. doi:10.1016/j.ijpharm.2011.10.030 

Flipo, M.; Desroses, M.; Lecat-Guillet, N.; Villemagne, B.; Blondiaux, N.; Leroux, F.; Piveteau, C.; Mathys, V.; Flament, M.P.; Siepmann, J.; Villeret, V.; Wohlkonig, A.; Wintjens, R.; Soror, S.; Christophe, T.; Jeon, H.K.; Locht, C.; Brodin, P.; Deprez, B.; Baulard, A.; Willand, N., Ethionamide boosters Part 2: Combining bioisosteric replacement and structure-based drug design to solve pharmacokinetic issues in a series of potent 1,2,4-oxadiazole EthR inhibitors, Journal of Medicinal Chemistry 2012, 55, 68-83. doi: 10.1021/jm200825u 

Le, V.N.P.; Hoang Thi, T.H.; Robins, E.; Flament, M.P., In vitro evaluation of powders for inhalation : the effect of drug concentration on particle detachment, International Journal of Pharmaceutics 2012, 424, 44-49. doi:10.1016/j.ijpharm.2011.12.020

Jean Baptiste, E.; Blanchemain, N.; Martel, B.; Neut, C.; Hildebrand, H.F.; Haulon, S., Safety, Healing, and Efficacy of Vascular Prostheses Coated With Hydroxyproyl-b-Cyclodextrin Polymer: Experimental in vitro and animal studies, European Journal of Vascular and Endovascular Surgery 2012, 43, 188-197. doi:10.1016/j.ejvs.2011.10.017

Güres, S.; Siepmann, F.; Siepmann, J.; Kleinebudde, P., Drug release from extruded solid lipid matrices: Theoretical predictions and independent experiments, European Journal of Pharmaceutics and Biopharmaceutics 2012, 80, 122–129. doi: 10.1016/j.ejpb.2011.10.002  

Moebus, K.; Siepmann, J.; Bodmeier R., Cubic phase-forming dry powders for controlled drug delivery on mucosal surfaces, Journal of Controlled Release 2012, 157, 206–215. doi:10.1016/j.jconrel.2011.09.075